FDA · Drug recall
Thyroid…
- Date
- Jan. 28, 2026
- Risk class
- Class II (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote)
- Status
- Ongoing
- Filed by
- Specialty Process Labs LLC
- Product
- Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02
- Reason
- Subpotent Drug
- Distribution pattern
- U.S. Nationwide
- Quantity
- 58 gms
- Codes and lots
- Lot #H22254-1XV; Exp. 01/31/2027
- Recall started
- Jan. 16, 2026
- Recall number
- D-0294-2026
What should I do? Medicine recall: what to do
Source: FDA · Drug enforcement report, recall number D-0294-2026. The agency record governs; check it and the company before acting.